Selegiline, or the problem of early termination of clinical trials - The clinical questions are not well answered, and probably never will be

被引：8

作者：

Breteler, MMB ^{[1
]}

机构：

[1] Erasmus Univ, Sch Med, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands

来源：

BRITISH MEDICAL JOURNAL | 1998年 / 316卷 / 7139期

关键词：

D O I：

10.1136/bmj.316.7139.1182

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1182 / 1183

页数：2

共 7 条

[1] Investigation by Parkinson's disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early mild Parkinson's disease: further results of randomised trial and confidential inquiry [J].

Ben-Shlomo, Y ;

Churchyard, A ;

Head, J ;

Hurwitz, B ;

Overstall, P ;

Ockelford, J ;

Lees, AJ .

BRITISH MEDICAL JOURNAL, 1998, 316 (7139) :1191-1196

[2] Prevalence of Parkinson's disease in the elderly: The Rotterdam study [J].

deRijk, MC ;

Breteler, MMB ;

Graveland, GA ;

Ott, A ;

Grobbee, DE ;

vanderMeche, FGA ;

Hofman, A .

NEUROLOGY, 1995, 45 (12) :2143-2146

[3] Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease [J].

Lees, AJ .

BRITISH MEDICAL JOURNAL, 1995, 311 (7020) :1602-1607

[4]

LEES AJ, 1996, BRIT MED J, V312, P702

[5] Selegiline and mortality in Parkinson's disease [J].

Olanow, CW ;

Fahn, S ;

Langston, JW ;

Godbold, J .

ANNALS OF NEUROLOGY, 1996, 40 (06) :841-845

[6]

SHOULSON I, 1989, NEW ENGL J MED, V321, P1364

[7]

Silva MT, 1997, BRIT MED J, V315, P370

← 1 →